Multiple Sclerosis Research and CBD (Cannabidiol)
Care and Feeding of Your Endocannabinoid System
Human Already Have an Endocannabinoid System One of the greatest advantages for publicly traded companies is their ability to raise capital in public markets. Capital can be used to fund research and development (R&D), fund capital expenditure, or even be used to pay off existing debt. This advantage is even more crucial for small biotechnology companies. Because of long lead... ContinueEndocannabinoid System – ECS the Secret To Balanced Health?
The Endocannabinoid System: The Secret To Balanced Health? “I would like to probably push ahead and tell people: Here we have a group of compounds… an endogenous system of major importance… it is not being used as much as it should be in the clinic… it is of great promise in the clinic… let’s try to push it forward.” –... ContinueSynthetic CBD vs Whole Plant CBD
Big Pharma’s Big Problem: How Whole Plant CBD Is Turning the Tables On Synthetic CBD Big Pharma’s playbook for drug development and patents is the same as it’s always been. Large pharmaceutical companies will either invest billions into research and development and ride the seven-year journey from a drug’s discovery, to patent, to its first commercial sale, or they skip... Continue
Multiple Sclerosis (MS) Research Continued
- Sativex for the management of multiple sclerosis symptoms
- THC & CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis
- Clinical efficacy and effectiveness of Sativex, a combined cannabinoid medicine, in multiple sclerosis-related spasticity
- CBD provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- Oromucosal delta9-THC/CBD for neuropathic pain associated with multiple sclerosis
- Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
- Sativex long-term use: An open-label trial in patients with spasticity due to multiple sclerosis
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
- Sativex: Clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain
